Gene · 4192
Papers2,993
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,993
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. | Cancers (Basel) | 2023 | 36980732 | PubTator, text mining | PubMed |
| Conditioned Media from Head and Neck Cancer Cell Lines and Serum Samples from Head and Neck Cancer Patients Drive Catabolic Pathways in Cultured Muscle Cells. | Cancers (Basel) | 2023 | 36980729 | PubTator, text mining | PubMed |
| Single cell analysis in head and neck cancer reveals potential immune evasion mechanisms during early metastasis. | Nat Commun | 2023 | 36973261 | PubTator, text mining | PubMed |
| Application of small extracellular vesicles in the diagnosis and prognosis of nasopharyngeal carcinoma. | Front Cell Dev Biol | 2023 | 36968209 | PubTator, text mining | PubMed |
Spatiotemporally deciphering the mysterious mechanism of persistent HPV-induced malignant transition and immune remodelling from HPV-infected normal cervix, precancer to cervical cancer: Integrating single-cell RNA-sequencing and spatial transcriptome. | Clin Transl Med | 2023 | 36967539 | PubTator, text mining | PubMed |
| Exposure to nonanoic acid alters small intestinal neuroendocrine tumor phenotype. | BMC Cancer | 2023 | 36959559 | PubTator, text mining | PubMed |
| Prognostic and immunological characteristics of CDK1 in lung adenocarcinoma: A systematic analysis. | Front Oncol | 2023 | 36950551 | PubTator, text mining | PubMed |
| Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers. | Mol Cancer | 2023 | 36941614 | PubTator, text mining | PubMed |
| Measurement of Complement Activation via Plasma-Soluble C5b-9 Comparison with Terminal Complement Complex Staining in a Series of Kidney Biopsies. | Kidney Blood Press Res | 2023 | 36917968 | PubTator, text mining | PubMed |
| JAK/STAT pathway: Extracellular signals, diseases, immunity, and therapeutic regimens. | Front Bioeng Biotechnol | 2023 | 36911202 | PubTator, text mining | PubMed |
| Recent progress in targeted therapy for non-small cell lung cancer. | Front Pharmacol | 2023 | 36909198 | PubTator, text mining | PubMed |
| A novel prognostic scoring model based on copper homeostasis and cuproptosis which indicates changes in tumor microenvironment and affects treatment response. | Front Pharmacol | 2023 | 36909185 | PubTator, text mining | PubMed |
| Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration. | Cell Death Discov | 2023 | 36906597 | PubTator, text mining | PubMed |
| The Role of Natural and Semi-Synthetic Compounds in Ovarian Cancer: Updates on Mechanisms of Action, Current Trends and Perspectives. | Molecules | 2023 | 36903316 | PubTator, text mining | PubMed |
| Epigenetic Abnormalities in Chondrosarcoma. | Int J Mol Sci | 2023 | 36901967 | PubTator, text mining | PubMed |
| Updating the Clinical Application of Blood Biomarkers and Their Algorithms in the Diagnosis and Surveillance of Hepatocellular Carcinoma: A Critical Review. | Int J Mol Sci | 2023 | 36901717 | PubTator, text mining | PubMed |
| Editorial: Epithelial-mesenchymal transition (EMT) as a therapeutic target in cancer. | Front Oncol | 2023 | 36890820 | PubTator, text mining | PubMed |
| SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory circuitry. | Nat Commun | 2023 | 36882421 | PubTator, text mining | PubMed |
| Identification of phenotypically, functionally, and anatomically distinct stromal niche populations in human bone marrow based on single-cell RNA sequencing. | Elife | 2023 | 36876630 | PubTator, text mining | PubMed |
| A 3D cell culture system for bioengineering human neuromuscular junctions to model ALS. | Front Cell Dev Biol | 2023 | 36866276 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4192/papers?page=28